Virios therapeutics to report fourth quarter and full year 2022 financial results on tuesday, march 14, 2023

Atlanta, march 07, 2023 (globe newswire) -- virios therapeutics, inc. (nasdaq: viri), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“fm”), announced today that it will report fourth quarter and full year 2022 financial results on tuesday, march 14, 2023 before the open of the financial markets.
VIRI Ratings Summary
VIRI Quant Ranking